Abstract
Insulin regulates glucose uptake by normal tissues. Although there is evidence that certain cancers are growth‐stimulated by insulin, the possibility that insulin influences tumor glucose uptake as assessed by 18F‐2‐Deoxy‐2‐Fluoro‐D‐Glucose Positron Emission Tomography (FDG‐PET) has not been studied in detail. We present a model of diet‐induced hyperinsulinemia associated with increased insulin receptor activation in neoplastic tissue, and with increased tumor FDG‐PET image intensity. Metformin, which has been associated with reduced cancer burden among diabetics, abolished the increase in insulin levels, tumor insulin receptor activation, and FDG‐PET signal associated with the high‐energy diet, but had no effect on these measurements in mice on a control diet. These findings suggest that for a subset of neoplasms, diet and insulin are variables that affect tumor FDG‐PET results, and have implications for design of clinical trials of metformin as an anti‐neoplastic agent.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
